FDS enters its final weeks before the June 18 earnings print with a positioning story that has shifted sharply in a single week — short interest has jumped nearly 35% in seven days, even as the stock recovered modestly from a bruising month.
Short interest is the standout on FDS this week, and the numbers are not subtle. SI as a percentage of free float has vaulted from roughly 9.7–10.0% across most of April to 13.75% as of April 28 — a 35% week-on-week surge. That move arrived almost entirely between April 22 and April 24, with estimated short shares jumping from roughly 3.8 million to just under 5.0 million in two sessions. The ORTEX short score has tracked higher in step, climbing from 54.9 on April 15 to 62.5 by April 28 — putting it in the 9th percentile of short-score rank across the universe, meaning few stocks score more bearishly. The rebuilding of short positions is the clearest active narrative on the stock right now.
The borrow market has not tightened to match the new short interest level, which is itself an interesting divergence. The cost to borrow is running at 0.42% — effectively negligible, little changed from March levels despite the surge in shorts. Availability, however, has tightened in step with the short build: the lending pool is now at its tightest level of the past 52 weeks, a signal that the newly opened shorts consumed a meaningful portion of available supply even if borrow costs haven't yet moved. Options positioning adds a layer of defensiveness. The put/call ratio is at 0.946, about 1.25 standard deviations above its 20-day average of 0.81 — not an extreme reading relative to the 52-week high of 1.52, but notably more protective than the 0.62–0.73 range that prevailed through early April. Taken together, the positioning picture is one of accelerating short conviction at a still-accessible borrow cost.
The Street has been broadly cautious on FDS for several months, and the recent analyst moves reinforce that tone. The most notable action came from Goldman Sachs on April 1, where analyst George Tong maintained a Sell rating while cutting the price target from $253 to $217 — a target now sitting below the current $232 price. Wells Fargo and Barclays have both held Underweight ratings through multiple target reductions this year. On the bullish side, UBS carries a Buy rating but trimmed its target from $425 to $380 on the same day as the Goldman move, reflecting a wider recalibration following the Q2 fiscal results released March 31. The mean analyst price target of $252 implies modest upside from current levels, though the distribution of views is wide. The bull case rests on FactSet's entrenched buy-side client base and active investment in AI-integrated analytics — most visibly demonstrated by the April 29 announcement of an expanded collaboration with J.P. Morgan on whole portfolio distribution tools. The bear case centres on margin pressure, elongating sales cycles in investment banking, and structural competitive risk from AI commoditising financial data.
Valuation sits in a reasonable zone but has expanded on the month. The trailing PE is near 12.6x — up about 1.1 points over 30 days — and EV/EBITDA is around 10.1x. The EPS momentum factor scores a creditable 68th percentile on the 30-day measure, and the dividend score ranks in the 99th percentile, though the dividend history data is significantly dated and should not be treated as current. Factor scores outside those two are broadly neutral: EPS surprise at the 46th percentile, forward EPS growth at the 45th, suggesting the Street is not pricing in a meaningful acceleration.
The institutional picture offers one noteworthy signal. Baron Capital added over 900,000 shares as of its February 28 filing, lifting its stake to 10.4% of shares outstanding — making it the second-largest institutional holder. That is a substantial, concentrated position from an active manager whose conviction appears to run counter to the short build. Meanwhile, MORN — the closest peer at 79% correlation — gained 0.8% on the week, while SPGI and MSCI were each down around 1.5–1.6%. FDS itself fell 4.3% on the week before recovering 1.2% on April 29, underperforming most of the peer group.
The March 31 earnings print — which produced a 9.9% single-day gain and a 11.3% five-day move — reset expectations sharply higher, and the next test arrives June 18. Whether the fresh wave of shorts is hedging against that strong post-earnings price level or expressing a view on deteriorating fundamentals is the question the data cannot answer; what the data does say is that the rebuild has been unusually fast, availability is at a 52-week low, and the short score is rising into the next print.
See the live data behind this article on ORTEX.
Open FDS on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
